Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | GALR3 | O60755 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7540217 | 0.76 | TSHR (0.59) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL28381924 | 0.75 | — | — | |
| SCHEMBL23529416 | 0.73 | TSHR (0.39) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL1289450 | 0.72 | TSHR (0.37) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL9796747 | 0.71 | TSHR (0.53) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL784062 | 0.69 | — | — | |
| SCHEMBL9752799 | 0.67 | TSHR (0.48) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL31037010 | 0.65 | TSHR (0.46) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL725912 | 0.65 | TSHR (0.60) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL2699105 | 0.64 | TSHR (0.59) | TSHRCHRM2CHRM4CHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378362-B2 | Polydiorganosiloxane preparation | DOW SILICONES CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| US-20230013216-A1 | POLYDIORGANOSILOXANE PREPARATION | DOW SILICONES CORPORATION | 2023-01-19 | — | — | US | claimed |
| EP-4077482-A1 | POLYDIORGANOSILOXANE PREPARATION | Dow Silicones Corporation (US) | 2022-10-26 | — | — | EP | claimed |
| WO-2021119972-A1 | POLYDIORGANOSILOXANE PREPARATION | DOW SILICONES CORPORATION (US) | 2021-06-24 | — | — | WO | claimed |
| US-12624168-B2 | Methods for making polyfunctional organosiloxanes and compositions containing same | DOW SILICONES CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260118791-A1 | TONER | CANON KK (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4086705-B1 | TONER | CANON KK (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4012501-B1 | EXTERNAL ADDITIVE FOR TONER, TONER AND IMAGE FORMING APPARATUS | CANON KK (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-3654105-B1 | PROCESS CARTRIDGE AND IMAGE FORMING APPARATUS | CANON KK (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4519346-B1 | SILICONE-POLYETHER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2026-01-14 | — | — | EP | disclosed |
| US-12497509-B2 | Method for manufacturing a silicone elastomer article using a 3D printer | ELKEM SILICONES FRANCE SAS (FR) | 2025-12-16 | — | — | US | disclosed |
| US-12487539-B2 | Fine particle, external additive for toners, and toner | CANON KABUSHIKI KAISHA (JP) | 2025-12-02 | — | — | US | disclosed |
| WO-2012134784-A1 | COMPOSITIONS CONTAINING PHOSPHONATE CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012134786-A1 | COMPOSITIONS CONTINING SULFONIC ACID CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012134788-A1 | COMPOSITIONS CONTAINING PHOSPHATE CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012047312-A1 | BIODEGRADABLE HYDROPHOBIC CELLULOSIC SUBSTRATES AND METHODS FOR THEIR PRODUCTION USING REACTIVE SILANES | DOW CORNING CORPORATION (US) | 2012-04-12 | — | — | WO | disclosed |
| US-8142856-B2 | Preparing hydrolyzate containing polysiloxanes by hydrolyzing hydrolysable silane or hydrolysable silane mixture in presence of acid hydrolysis catalyst andcombining polysiloxane hydrolyzate with mineral and/or filler and optionally with water and/or a catalyst for condensation of the hydrolyzate | DOW CORNING CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-20080286474-A1 | Hydrophobing Minerals and Filler Materials | DOW SILICONES CORPORATION | 2008-11-20 | — | — | US | disclosed |
| EP-1904415-A2 | HYDROPHOBING MINERALS AND FILLER MATERIALS | Dow Corning Corporation (US) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007009935-A2 | HYDROPHOBING MINERALS AND FILLER MATERIALS | DOW CORNING CORPORATION (US) | 2007-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118791-A1 | TONER | MSR1, H1-2, TAAR1 | TSHR 165/4885CHRM2 23/4885CHRM4 159/4885 |
| US-12624168-B2 | Methods for making polyfunctional organosiloxanes and compositions containing same | HAO2, H1-2, HRH2 | TSHR 549/4885CHRM2 202/4885CHRM4 945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.